Evidence map›Paper›PMID 31547831›Full record

ArticleItalian journal of pediatrics2019

A solution based on melatonin, tryptophan, and vitamin B6 (Melamil Tripto©) for sedation in newborns during brain MRI.

S Picone, P Ariganello, V Mondì, F Di Palma, L Martini, S Marziali, G Fariello, P Paolillo

Open access · goldAbstract read
In one paragraph

Article in Italian journal of pediatrics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 11 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

S PiconeNeonatology and Neonatal Intensive Care Department, Policlinico Casilino General Hospital, Via Casilina 1069, 00169, Rome, Italy. simpico@libero.it.ORCID http://orcid.org/0000-0003-3145-9431
P AriganelloNeonatology and Neonatal Intensive Care Department, Policlinico Casilino General Hospital, Via Casilina 1069, 00169, Rome, Italy.
V MondìNeonatology and Neonatal Intensive Care Department, Policlinico Casilino General Hospital, Via Casilina 1069, 00169, Rome, Italy.
F Di PalmaMedical School, La Sapienza University, Piazzale Aldo Moro 5, Rome, Italy.
L MartiniNeonatology and Neonatal Intensive Care Department, Policlinico Casilino General Hospital, Via Casilina 1069, 00169, Rome, Italy.
S MarzialiDepartment of Neuroradiology, Policlinico Casilino General Hospital, Via Casilina, 1069, Rome, Italy.
G FarielloDepartment of Neuroradiology, Policlinico Casilino General Hospital, Via Casilina, 1069, Rome, Italy.
P PaolilloNeonatology and Neonatal Intensive Care Department, Policlinico Casilino General Hospital, Via Casilina 1069, 00169, Rome, Italy.
Policlinico Casilino · ITSapienza University of Rome · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionMelatonin has been studied and used for several years as a sleep-wake cycle modulator in patients with sleep disorders. Experimental evidence has demonstrated the multiple neuroprotective benefits of this indoleamine secreted by the pineal gland. Melatonin is also used in neurological investigations, for its ability to induce sleep in children. In fact, it favors falling asleep during electroencephalogram, Magnetic Resonance Imaging (MRI), and during brainstem auditory evoked potentials. Previous studies are focused on infants and children. No investigation have been performed in neonates, before or during instrumental assessments. MATERIAL AND

methodsOne hundred ten newborns (term and preterm) undergoing brain MRI were enrolled in the study. Thirty minutes before the planned time for the examination, we administered a single dose solution of melatonin- tryptophan-vitamin B6. Twenty minutes after the initial administration of 2 mg, a second dose of 1 mg was administered, if the baby was still awake. If after further 15 min the baby was still not sleeping, an additional dose of 1 mg was administered.

resultsIn 106 patients we obtained adequate sedation without adverse events, allowing us to perform an adequate quality MRI, with a median time of 25 min to reach sleeping. Only in three patients MRI could not be performed. In patients having a large weight, higher doses of melatonin were necessary to reach sleeping. Considering the pro kg dose of melatonin, the average dose that induced sleepiness in neonates was 0,64 ± 0.16 mg/Kg.

conclusionA solution based on Melatonin- tryptophan-vitamin B6 can be a helpful sedative to administer to neonates undergoing brain MRI, avoiding the use of anesthetics and achieving adequate assessments.

Indexed as

Magnetic Resonance ImagingAntidepressive Agents, Second-GenerationBrainCentral Nervous System DepressantsFemaleHumansHypnotics and SedativesInfantInfant, NewbornMaleMelatoninProcedural SedationRetrospective StudiesTryptophanVitamin B 6Vitamin B ComplexAntidepressive Agents, Second-GenerationCentral Nervous System DepressantsHypnotics and SedativesMelatoninTryptophanVitamin B 6Vitamin B ComplexBrain MRIMelatoninNeonatal sedation

Identifiers

PMID31547831
PMCPMC6757392
OpenAlexW2976073123

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.